Primitive hyperparathyroidism (pHPT) is the most common form of hyperparathyroidism. The asintomatic form (apHPT) accounts for 75-80 percent of cases and is characterized by minimal symptoms secondary to high levels of calcemia. Bisphosphonate and calciomimetic drugs represent a potential alternative to the surgery in the treatment of apHPT patients, but at the present there are not guidelines on medical therapy in the management of these kind of patients.
|Translated title of the contribution||The management of the patient with asymptomatic primitive hyperparathyroidism: One still open controversy|
|Number of pages||4|
|Journal||Recenti Progressi in Medicina|
|Publication status||Published - Jun 2006|
ASJC Scopus subject areas